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India has been recognized all over the world for spices and medicinal plants. Both exhibit a wide range of 
physiological and pharmacological properties. Current biomedical efforts are focused on their scientific merits, 
to provide science-based evidence for the traditional uses and to develop either functional foods or nutraceuti-
cals. The Indian traditional medical systems use turmeric for wound healing, rheumatic disorders, gastrointesti-
nal symptoms, deworming, rhinitis and as a cosmetic. Studies in India have explored its anti-inflammatory, 
cholekinetic and anti-oxidant potentials with the recent investigations focusing on its preventive effect on pre-
carcinogenic, anti-inflammatory and anti atherosclerotic effects in biological systems both under in vitro and in 
vivo conditions in animals and humans. Both turmeric and curcumin were found to increase detoxifying en-
zymes, prevent DNA damage, improve DNA repair, decrease mutations and tumour formation and exhibit anti-
oxidative potential in animals.  Limited clinical studies suggest that turmeric can significantly impact excretion 
of mutagens in urine in smokers and regress precancerous palatal lesions. It reduces DNA adducts and micro-
nuclei in oral epithelial cells. It prevents formation of nitroso compounds both in vivo and in vitro.  It delays 
induced cataract in diabetes and reduces hyperlipidemia in obese rats.  Recently several molecular targets have 
been identified for therapeutic / preventive effects of turmeric. Fenugreek seeds, a rich source of soluble fiber 
used in Indian cuisine reduces blood glucose and lipids and can be used as a food adjuvant in diabetes.  Simi-
larly garlic, onions, and ginger have been found to modulate favourably the process of carcinogenesis. 
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INTRODUCTION  
Mounting health care costs and increased desire to maintain 
good health and quality of life have focussed the research-
ers’ and public health scientists’ attention on the diet, 
phytonutrients, disease prevention and health promotion. 
Biomolecules in the plants play a crucial role in health 
maintenance and promotion.1 In Asian countries; particu-
larly, India, China, Japan and Korea; there is a longstand-
ing tradition and culture of attributing healing properties to 
foods and plant materials. They have an extra-ordinary 
place in the realm of traditional cures as medicines.2. There 
is a treasure house of knowledge, which needs to be ex-
plored to establish the scientific basis of its benefits. Phyto-
chemicals in spices, which primarily serve in plant protec-
tion, are considered vitamins of the 21st Century. They are 
also less toxic compared to drugs. This article captures 
some recent scientific findings on turmeric, fenugreek, 
mustard, ginger, onions and garlic, which are common 
spices and have a distinct place in folk medicine in several 
of Asian countries. 
 
STUDIES ON TURMERIC  
Turmeric cultivation in India occupies 60% of the total area 
intended for spices and condiments.  It is not only an an-
cient but also a highly cultivated Asian spice and used in 
countries like India, China, Malaysia, Pakistan, Bangladesh, 
Indonesia, Taiwan, Haiti, Jamaica and El-Salvador. Tradi-
tionally turmeric is used in a variety ways for different 
diseases, due to its kaleidoscopic properties3, for example 
as a general tonic, stimulant, cosmetic and for the treatment  
of coughs, colds, soar throats, asthma and dyspepsia includ-
ing peptic ulcers. It is also used as a deworming agent and 
as a paste for some viral diseases such as chicken pox, 
small pox and measles. It is liberally used in arthritis and 
for wound healing. These traditional uses are a reflection of 
its pleiotropic effects. Current literature abounds in scien-
tific evidences supporting its traditional uses and evidence 
based science clearly shows that turmeric and its active 
constituents, particularly curcuminoids can be used for a 
variety of disorders.3 
    Turmeric is a popular spice derived from the root of 
Curcuma longa Linn, a member of the ginger family.  The 
powder and its active principle, a group of curcuminoids, 
are widely used as: culinary spices, preservatives, food 
additives, cosmetics, and as oleoresin in food and pharma-
ceutical industries. In the last two decades, there has been 
considerable interest among the biomedical scientists to 
explore the possible therapeutic benefits of turmeric and its 
active principle, curcuminoids. A considerable amount of 
work has been carried out to explain its molecular, cellular, 
biochemical and pathological mechanisms to establish its 
potential as a therapeutic agent for many chronic diseases.4 
 
CHEMICAL AND NUTRITIONAL COMPOSITION 
Curcuma longa Linn or turmeric is a tropical plant native to   
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South and Southeast tropical Asia. It is a rhizomatous 
herb that belongs to the family Zingiberaceae. The major 
species is genus Curcuma longa Linn which is of com-
mercial value. The rhizomes, on maturity, are steeped in 
boiling water, sun dried and polished to obtain the tur-
meric sticks. The powder form is used in various dishes. 
Turmeric contains essential oils, fatty oils and 2-5% cur-
cuminoids.5. Certain varieties, contain up to 9% curcumi-
noids. It has all proximate principles such as carbohy-
drates, proteins and fats and provides all nutrients in small 
quantities. Turmeric is fairly rich in omega-3 fatty acids. 
Curcuminoids are polyphenolic compounds with a β-
diketone moiety. The 3 types of curcuminoids, namely 
Curcumin I, II and III, differ with regard to their hydroxyl 
and methyl groups. Current efforts in research are focused 
on evidence-based science to determine the functional 
benefits of their bioactive compounds.3 Whole turmeric or 
the extracted curcuminoids appear to be active in many 
disease processes with specific reference to chronic ail-
ments such as cardiovascular, degenerative, infective and 
inflammatory disorders as well as cancers. 
  
ANTIMUTAGENIC EFFECTS 
The antimutagenic potential of turmeric was assessed 
against the ubiquitous pollutant benzo(a)pyrene [B(a)P] in 
rats. Turmeric, at 1, 5 and 10% of the diet, were fed to the 
rats for three months. At the end of each month, after giv-
ing 5 mg of B(a)P per rat,  urine samples were collected 
for 24 hours in which mutagens were quantitated. The 
salmonella strains of TA98 and TA100 with and without 
S9 fraction were used for the quantitation of mutagens. 
Mutagens in urine were significantly reduced by dietary 
exposure to turmeric. No additional effects were observed 
beyond 1 month. Further studies were done with 0.1 and 
0.5 % turmeric with B(a)P  and 3 methyl cholanthrene. 
Dose dependent results were observed with the 0.5% tur-
meric in the diet, indicating a potent effect even against a 
strong inducer such as methylcholanthrene.6 
As curcuminoids are important constituents of turmeric 
and is similar to ellagic and ferulic acids which are an-
timutagens, the antimutagenic effects of curcuminoids 
were assessed in the animals with methods described in 
the previous study. Curcumin, with or without S9 fraction, 
significantly reduced mutagens at all levels within four 
weeks of feeding,. The doses correspond to 0.5 to 5% of 
turmeric in the diet. The parahydroxy groups/diketone 
moiety are considered important for activity.7   
 
PROTECTIVE EFFECTS ON DNA 
In rats treated with dietary turmeric and curcumin for one 
month, both the number of adducts and the micrograms of 
adducted DNA were significantly impacted by 0.1% tur-
meric and 0.03% of curcumin. This was determined with 
the use of P32 post label assay. The percentage of reduc-
tion ranged from 61 to 70% for 0.1 to 3% turmeric re-
spectively while curcumin (0.03%) resulted in 92% re-
duction.8 
A more recent study showed that breaks in the DNA 
strand in the peripheral cells were effectively repaired by 
curcumin and S.cerevisiae exposed to χ irradiation. The 
protective effect of curcumin on B(a)P induced DNA 
damage in human peripheral blood , as  assessed by comet 
assay, showed a dose-dependent inhibitory effect.9 
 
TURMERIC AND CURCUMIN ON XENOBIOTIC 
METABOLISM 
Ingested environmental chemicals need to be eliminated 
from the body to protect against toxicity. The body has a 
defence system in the form of drug metabolising enzymes 
located in the GI tract and liver and certain extra hepatic 
tissues like the kidneys and lungs. The liver and the GI 
tract act as first line of defence against lipophilic sub-
stances. Several plant materials known to be inhibitors of 
carcinogenic process are reported to enhance the host 
detoxification mechanisms and act as blocking agents.  
Enzymes such as aryl hydrocarbon hydroxylase (AHH), 
Uridine diphosphoglucuronide transferase (UDPGT) and 
Glutathione-S-transferase(GSHT) were therefore assessed 
in rats after 4 weeks of turmeric and or curcumin feeding. 
The AHH was not altered either by turmeric or curcumin 
feeding neither in the liver nor in the GI tract. However, 
GSHT activity was significantly elevated both in the liver 
and in the intestine at low levels of turmeric and curcumin 
intake. Elevation ranged from 25-30%. GSHT is one of 
the versatile enzymes that mop up electrophilic sub-
stances. The increased in GSHT activity in animals fed 
large amounts of cruciferous vegetables and fruits corre-
lates well with their anticarcinogenic potential in fore-
stomach tumours induced by B(a)P. The non-stimulatory 
effect of turmeric and curcumin on AHH as against induc-
ing effects on GSHT would ultimately decrease the load 
of carcinogen on the body.10 Several other enzymes such 
as quinone reductase, epoxide and hydrolase are also in-
creased by both turmeric and curcumin.3 
 
TURMERIC AND CURCUMIN AS ANTIOXI-
DANTS 
Turmeric and curcumin show antioxidant activity in vitro. 
The antioxidant effects of turmeric and curcumin were 
therefore evaluated in vivo where oxidant damage was 
induced by paracetamol and DMBA. Markers such as 
MDA levels as an indicator of lipid peroxidation, glu-
tathione in liver homogenate, superoxide dismutase and 
glutathione peroxide were estimated. Thiobarbituric acid 
reactive substances were much lower in turmeric and cur-
cumin treated rats when compared to controls and so was 
the case with ALT levels in serum, indicating that liver 
damage due to the paracetamol metabolite N-acetyl 
amino-paraamino benzoquinone was counteracted by cur-
cumin. This suggests that the oxidative metabolite of 
paracetamol is detoxified by increased activity of GSHT.3 
 
TUMOUR INHIBITION 
As oral cancers are highly prevalent in India, the experi-
mental model of hamster cheek pouch was employed to 
study the effects of turmeric and curcumin on DMBA 
induced tumour genesis. The burden of tumours and the 
number of tumours per animal were significantly reduced 
at 1% turmeric in the diet. The tumours were larger in 
size in the control groups as compared to those that re-
ceived either turmeric or curcumin.11 However, curcumin 
effects varied between groups. Since GI tract tumours 
such as oesophageal and stomach cancers are widely 
Traditional Indian spices and their health significance                                                267 
prevalent in several states of India, it was considered nec-
essary to assess its effects on the initiation promotion 
model of fore-stomach tumours, induced by B(a)P, in 
mice. Histopathological grading was done on a scale of 1-
10 of which 6-10 is malignant proliferation.  The prolif-
eration index in the treated groups was significantly lower. 
Turmeric was effective during both the initiation and 
post-initiation phases while curcumin appears to be effec-
tive only during the initiation phase, with minimal effects 
on post-initiation phase. From a pathological point of 
view, the evolving carcinogenic process is a sequential 
change from a normal homogenous group to a more het-
erogeneous group and turmeric appears to control pre-
malignant and precancerous lesions as well malignant 
transformation.3 
 
EFFECT OF TURMERIC ON IN VIVO NITROSA-
TION  
Since nitrosocompounds are known to increase the risk of 
the development of gastrointestinal tract cancers and anti-
oxidants such as selenium and vitamin C inhibit nitrosa-
tion, turmeric was assessed for its nitrosation inhibition 
activities in human volunteers. Turmeric, even at low 
concentrations, inhibited (22.7%) nitrosoproline excre-
tion.3  
 
MOLECULAR MECHANISMS 
Curcuminoids have a wide sweep of complex molecular 
actions. It arrests the cell cycle (anti-proliferative), pro-
motes differentiation, inhibits several biochemical and 
molecular process (signal transduction, transcription), 
oncogenic expressions to growth factors, angiogenesis 
and promotes apoptosis. It inhibits inflammatory process 
through the reduction of TNF-alpha and cytokines, 
chemokines and prostaglandin inhibition.4 
 
ANTI-ATHEROSCLEROTIC EFFECTS 
In a natural mutant model of obesity, turmeric (at 1 and 
5% of the diet) had significantly reduced cholesterol and 
triglyceride concentrations while increasing HDL choles-
terol, within 4 weeks. Further evidence indicates that it 
reduces the oxidation of LDL, blood glucose and renal 
lesions in diabetes.  In addition, it had been demonstrated 
to reduce platelet aggregation, cyclooxegenase, throm-
boxane, smooth muscle cell proliferation and endothelial 
dysfunction.3 
Both turmeric and curcumin, due to their antioxidant 
and anti-inflammatory activity, have been demonstrated 
to counteract several disorders such as myocardial infarc-
tions, chronic inflammatory lung diseases, pancreatitis, 
inflammatory bowel diseases, neurodegenerative diseases, 
hepatic and lung damages as well as muscle injuries and 
cystic fibrosis.3 Curcumin can also impact on the process 
of cataractogenesis and delays galactose-induced cataracts 
formation in rats.12 
 
CLINICAL TRIALS 
Several trials, albeit not very well designed, have shown 
positive effects. The antimutagenic effects of turmeric 
were assessed in humans who were known to excrete 
large amounts of mutagens in their urine. Turmeric, when 
administered in doses of 1.5 g/day for 30 days (extrapo-
lated doses from animal experiment) exhibited strong 
inhibition of urinary mutagens within a short period of 15 
days.13 A limited clinical straight trial was conducted in a 
group of reverse smokers who are known to be at high 
risk of palatal cancers. A dose of 1g/day of turmeric was 
administered for a period of 9 months, the results of 
which suggested that it had a significant impact on the 
regression of precancerous lesions and also impacted 
genotoxic damage.3 
 
TOXICITY 
Turmeric has been in use from time immemorial as a fla-
vouring and colouring agent and in folklore as a medica-
ment.  Toxicology studies on curcumin in various species 
of animals have yielded no toxic effects.  Human clinical 
trials have demonstrated no toxic effects at doses of 1-8g / 
day / 6-8 months. (see ref 3 for cross ref.) 
 
EFFECT OF COOKING  
As turmeric, in the Indian culinary practices, is usually 
either boiled or fried, the antimutagenic effects of boiled 
or friend turmeric were assessed in E.coli PQ37 based on 
the measure of SOS DNA repair.7 It was evident that 
boiled or fried turmeric evoked a similar SOS response, 
indicating that cooking at high temperatures is unlikely to 
destroy the antimutagenic potentials of turmeric. 
  
FENUGREEK AND ITS BIOLOGICAL EFFECTS 
Fenugreek, a native of South East Europe and West Asia 
belongs to the family of leguminacae and is an annual 
herb. The dried seeds of fenugreek are used as a spice 
while the leaves are used as a vegetable in the Indian cu-
linary arts. Fenugreek seeds is a rich source of protein, 
fibre and omega 3 fatty acids while the leaves are sources 
of beta-carotene, iron, calcium, magnesium, potassium 
and vitamin C. India is one of the major producers and 
exporters of fenugreek.  
 
HYPOGLYCEMIC EFFECTS 
Since fenugreek is a rich source of soluble fiber, several 
experiments were performed in animals to assess its ef-
fects on lipids and blood glucose. In a metabolic study 
with a crossover design in NIDDM patients, when 100g 
of defatted fenugreek seed powder was administered for a 
period of 10 days, significant reduction in glucose levels 
and increased glucose tolerance was observed.14 A reduc-
tion in serum insulin levels was also documented. When 
subjects received fenugreek for a period of 10 and 20 
days, there was not only a significant reduction in blood 
glucose but also a significant reduction in cholesterol, 
triglycerides and urinary sugar levels. The gel forming 
characters of fenugreek fiber reduces gastric emptying, 
glucose absorption and the insulin response. In a majority 
of patients, a mild improvement in clinical symptoms 
such as polydipsia and polyuria were observed with a 
reduction in anti-diabetic drug doses. Incorporating just 
around 25g fenugreek seeds in the daily diet can serve as 
an effective supportive therapy in the management of 
diabetes.  
     A study on glucose disposition was undertaken in type 
II diabetics before and after a diet consisting of fenugreek 
(25g) in unleavened bread. During the experimental    
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period, the intake of fibre was 42g as compared to 30g in 
the control group. There was a significant reduction in the 
area under the plasma glucose curve (AUC). The half-life 
of glucose was shorter and metabolic clearance of glucose 
was higher, RBC insulin receptors registered a significant 
increase. The results of the insulin binding sites coupled 
with the observations on insulin levels indicated better 
peripheral glucose utilization. Recent studies attribute the 
hypoglycemic effects to the amino acid, 4-
hydroxyisoleucine which may have effects on pancreatic 
beta cells. 
      
BIOPOTENCY OF ONION, GARLIC, MUSTARD 
AND GINGER. 
Garlic and ginger have many therapeutic attributes. An-
timicrobial, antithrombotic, antiinflammatory and anti-
cancer activity have been reported.15,16 Spices such as 
mustard, allium and ginger have been demonstrated to be 
antimutagenic, inducers of   detoxification, and preventers 
DNA damage in vitro.17,18,19  
 
CONCLUSION 
The relevance of the innumerable actions of spices shown 
in vitro, have to be demonstrated in vivo. The diversity of 
their cellular actions supports their possible beneficial 
effects on various chronic diseases. More rigorous clinical 
trials are needed to determine long-term benefits. The 
integration of knowledge is required to determine their 
effect in natural human settings. Turmeric, through its 
kaleidoscopic effects, appears to be truly a spice of life.    
Food based approaches for enhancing the intake of spices 
and   phytochemicals can offer an avenue to greatly im-
pact the onset and progression of chronic diseases, oxi-
dant stress and ageing. Although the chemopreventive 
approach is a recognized strategy, public health action 
should be directed at increases in the consumption of 
foods / herbs / spices / beverages, which posses a package 
of protective phytonutrients.  The phytoprotectants act as 
bioenhancers of several physical and biochemical proc-
esses. For chronic disorders, chemoprevention may not be 
a feasible strategy except for individuals at risk. Dietary 
prescription as a public health measure will be sustainable 
and cost effective. Spices such as turmeric, fenugreek, 
mustard, ginger, onion and garlic have a wide variety of 
bio functions and their additive or synergistic actions are 
likely to protect the human body against a variety of in-
sults. Traditionally spices, as part of the diets, have holis-
tic effects on human health.  
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